Evaluation of eosinophilia

Última revisão: 12 Jan 2026
Última atualização: 31 Dec 2024

Resumo

Diagnósticos diferenciais

comuns

  • Ascariasis
  • Strongyloidiasis
  • Schistosomiasis
  • Trichinellosis
  • Pemphigus
  • Bullous pemphigoid
  • Asthma
  • Eczema
  • Allergic rhinitis
Detalhes completos

Incomuns

  • Clonorchiasis
  • Fascioliasis
  • Fasciolopsiasis
  • Opisthorchiasis
  • Filariasis
  • Gnathostomiasis
  • Toxocariasis
  • Paragonimiasis
  • Ancylostoma caninum infestation
  • Coccidioidomycosis
  • Pemphigoid gestationis
  • Drug hypersensitivity
  • Drug rash with eosinophilia and systemic symptoms (DRESS)
  • Allergic bronchopulmonary aspergillosis
  • Eosinophilic granulomatosis with polyangiitis
  • Eosinophilic esophagitis
  • Eosinophilic gastroenteritis
  • Eosinophilic cellulitis (Wells syndrome)
  • Chronic eosinophilic leukemia
  • Other leukemias
  • Non-Hodgkin lymphoma
  • Hodgkin lymphoma
  • Nonhematologic malignancy-associated hypereosinophilia
  • Lymphocytic variant of hypereosinophilic syndrome
  • Idiopathic hypereosinophilic syndrome
  • Wiskott-Aldrich syndrome
  • Job syndrome
  • Hyperimmunoglobulin E syndrome
  • Severe combined immune deficiency due to adenosine deaminase deficiency
  • Omenn syndrome
  • immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome
  • Autoimmune lymphoproliferative syndrome (ALPS)
  • Loeys-Dietz syndrome
  • Comel-Netherton syndrome
  • Severe dermatitis, multiple allergies, and metabolic wasting (SAM) syndrome
  • Muscular sarcocystosis
  • Cystoisospora belli (formerly Isospora belli) infection
  • Anisakiasis
  • Loiasis
Detalhes completos

Colaboradores

Autores

Barbara J. Bain, MBBS, FRACP, FRCPath

Professor of Diagnostic Haematology

St Mary's Hospital Campus

Imperial College London

London

UK

Declarações

BJB is an author of a number of references cited in this topic.

James Uprichard, MBBS, BSc, PhD, FRCP, FRCPath

Consultant Haematologist

Department of Haematology

St George's University Hospitals NHS Foundation Trust

London

UK

Declarações

JU declares that he has no competing interests.

Revisores

Zeinab Afify, MD

Professor of Pediatrics

Department of Pediatrics

Division of Pediatric Hematology Oncology

University of Utah

UT

Declarações

ZA declares that she has no competing interests.

Jan Cools, PhD

Associate Professor

Department of Molecular and Developmental Genetics

Katholieke Universiteit Leuven

Leuven

Belgium

Declarações

JC is an author of a reference cited in this topic.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Valent P, Klion AD, Roufosse F, et al. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes. Allergy. 2023 Jan;78(1):47-59.Texto completo  Resumo

Williams KW, Milner JD, Freeman AF. Eosinophilia associated with disorders of immune deficiency or immune dysregulation. Immunol Allergy Clin North Am. 2015 Aug;35(3):523-44. Resumo

Butt NM, Lambert J, Ali S, et al; British Society for Haematology. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017 Feb;176(4):553-72.Texto completo  Resumo

Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022 Jul;36(7):1703-19.Texto completo  Resumo

Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022 Jan 1;97(1):129-48.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

O uso deste conteúdo está sujeito ao nosso aviso legal